The UK government is trying to placate the disgruntled life sciences industry by investing in mining health data and increasing the domestic manufacturing of vaccines and drugs.
Ministers are expected on Friday to unveil more than ￡150mn of funding for the UK Biobank, a pioneering genomics project, to quadruple its research capacity to advance scientists’ and drugmakers’ understanding of human biology.
The biobank will build a new facility in Manchester to store its 16mn samples and upgrade its IT infrastructure, according to officials.
您已閱讀18%（543字），剩余82%（2431字）包含更多重要信息，訂閱以繼續探索完整內容，并享受更多專屬服務。